Back to Search
Start Over
Choice of Initial Oral Therapy for Pulmonary Arterial Hypertension: Age and Long-Term Survival.
- Source :
-
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2018 Oct 15; Vol. 198 (8), pp. 1090-1093. - Publication Year :
- 2018
- Subjects :
- Administration, Oral
Age Factors
Bosentan administration & dosage
Bosentan therapeutic use
Drug Therapy, Combination
Endothelin Receptor Antagonists administration & dosage
Female
Humans
Hypertension, Pulmonary mortality
Male
Middle Aged
Phenylpropionates administration & dosage
Phenylpropionates therapeutic use
Phosphodiesterase 5 Inhibitors administration & dosage
Pyridazines administration & dosage
Pyridazines therapeutic use
Pyrimidines administration & dosage
Pyrimidines therapeutic use
Retrospective Studies
Sildenafil Citrate administration & dosage
Sildenafil Citrate therapeutic use
Sulfonamides administration & dosage
Sulfonamides therapeutic use
Tadalafil administration & dosage
Endothelin Receptor Antagonists therapeutic use
Hypertension, Pulmonary drug therapy
Phosphodiesterase 5 Inhibitors therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1535-4970
- Volume :
- 198
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- American journal of respiratory and critical care medicine
- Publication Type :
- Report
- Accession number :
- 29949380
- Full Text :
- https://doi.org/10.1164/rccm.201801-0059LE